Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export and supplierofEnoxaparin Sodium Injectionfrom Surat, Gujarat, India. Enoxaparin Sodium Injection Use during pregnancy appears to be safe for the baby.Enoxaparin is in the low molecular weight heparin family of medications.
Tags: Enoxaparin Sodium Injection manufacturer, Enoxaparin SodiumInjection exporter, Enoxaparin Sodium Injection supplier, and Enoxaparin SodiumInjection, whogmp approved Enoxaparin Sodium Injection manufacturer and supplier, Enoxaparin Sodium Injection distributor, Enoxaparin Sodium Injection shipper,Enoxaparin Sodium Injection 0.8 ml Enoxaparin Sodium Injection 0.8mlsupplier,Enoxaparin Sodium Injection 0.8 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility inGujarat, India.
Registration: Saintroy Lifescienceis interested inregistration of own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy LifescienceEnoxaparin SodiumInjection export to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Effective Blood Clot PreventionEnoxaparin Sodium Injection offers reliable protection against blood clot formation for adults, elderly patients, and women. It is prescribed for conditions such as deep vein thrombosis, pulmonary embolism, and during certain surgeries. Administered only under medical supervision, this injection ensures reduced risk of coagulation and improved patient outcomes.
Quality Assurance and Safe Distribution in IndiaAs a trusted manufacturer, supplier, dealer, and exporter based in India, we prioritize maintaining strict quality control standards. Product integrity is safeguarded throughout the supply chain, enabling consistent supply for healthcare providers, clinics, and hospitals. Our distribution network ensures timely and reliable delivery across the region.
FAQ's of Enoxaparin Sodium Injection:
Q: How should Enoxaparin Sodium Injection be administered?
A: Enoxaparin Sodium Injection must be administered as directed by a physician, typically as a subcutaneous injection. The healthcare provider decides the dosage and frequency based on the patient's condition and medical needs.
Q: What conditions can be treated with Enoxaparin Sodium Injection?
A: This injection is mainly used to prevent and treat blood clots, such as deep vein thrombosis and pulmonary embolism. It may also be recommended during surgeries or for patients at risk of clot formation, as advised by a doctor.
Q: When is it necessary to use Enoxaparin Sodium Injection?
A: A physician may prescribe Enoxaparin Sodium Injection when an individual is at increased risk for blood clots, such as after surgery, during prolonged immobilization, or when certain health conditions elevate clotting risk.
Q: Where should Enoxaparin Sodium Injection be stored?
A: For optimal effectiveness and safety, store Enoxaparin Sodium Injection in a cool, dry place, away from sunlight and moisture. Always keep it out of reach of children.
Q: What is the process for acquiring Enoxaparin Sodium Injection in India?
A: The medication is available through authorized dealers, distributors, exporters, and suppliers across India. It should only be dispensed with a valid prescription from a certified healthcare provider.
Q: How does Enoxaparin Sodium Injection benefit patients?
A: Enoxaparin Sodium Injection reduces the risk of serious and potentially life-threatening blood clots in patients, particularly those who are hospitalized, immobile, or undergoing surgery. This contributes to safer recovery and lower complication rates.